Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001185185-25-001520
Filing Date
2025-10-22
Accepted
2025-10-22 08:29:01
Documents
1
Period of Report
2025-10-17

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3969
  Complete submission text file 0001185185-25-001520.txt   5468
Mailing Address C/O AMPHASTAR PHARMACEUTICALS, INC. 11570 6TH STREET RANCHO CUCAMONGA CA 91730
Business Address
PRINS RICHARD K (Reporting) CIK: 0001047579 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32830 | Film No.: 251408659

Mailing Address 10224 FALLS ROAD POTOMAC MD 20854
Business Address 10224 FALLS ROAD POTOMAC MD 20854 301-529-4996
IGC Pharma, Inc. (Issuer) CIK: 0001326205 (see all company filings)

EIN.: 202760393 | State of Incorp.: MD | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)